Amgen Inc. (AMGN) Announced Q1 2026 Earnings on April 30, 2026, Reporting "4% growth in product sales"
Amgen announced Q1 2026 results, showing 4% product sales growth and $1.5 billion in free cash flow. The company is leveraging AI to accelerate drug development and manufacturing processes, and provided its full-year 2026 financial outlook.